At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 144 enrolled
Drug / intervention
No Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study to Evaluate and Explore Scales for Repetitive and Restricted Behaviors and Digital Biomarkers in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD)
In Brief
A Phase 1 clinical trial evaluating No Intervention for Autism Spectrum Disorder. Completed, enrolled 144 participants across 18 sites in 3 countries.
Detailed Summary
This is a non-drug study seeking to characterize different scales to measure repetitive and restrictive behaviors in different ASD sub-populations over time. This study will also explore the use of digital biomarkers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutism Spectrum Disorder
CountriesCanada, United Kingdom, United States
Collaborators--
Timeline
Phase 1CompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartAug 2018
Primary CompletionMay 2020
TodayJul 2026
First PostedAug 2, 2018
Enrollment StartAug 13, 2018
Primary CompletionMay 21, 2020
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 7.9 years ago
Interventions
No Interventionother
No interventions are administered in this study